Evidence supporting the use of: Spirulina
For the health condition: Cholera

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Spirulina, a blue-green algae, has garnered scientific interest for its potential in supporting the treatment of cholera, mainly due to its nutritional properties and some early clinical investigations. The most notable evidence comes from a study conducted in Bangladesh in 2005, where researchers evaluated the adjunct use of spirulina in the management of children with cholera. In this randomized controlled trial, children with cholera who received spirulina supplementation in addition to standard rehydration therapy showed a significantly faster reduction in stool volume and frequency compared to those receiving only standard therapy. The study suggested that spirulina might help improve the nutritional status and immune response of patients, potentially aiding in a faster recovery from acute diarrheal illnesses like cholera.

Despite these promising results, the overall body of evidence is limited. Most studies to date are small-scale, and there is a lack of large, multicenter trials to confirm the efficacy and safety of spirulina as an adjunctive therapy for cholera. The proposed mechanisms include spirulina's high protein content, presence of antioxidants, and immune-modulating effects, which may contribute to better outcomes in malnourished patients suffering from severe diarrhea. However, spirulina is not a replacement for standard cholera treatment, such as rehydration and antibiotics when indicated. In summary, while early scientific evidence exists, it is not robust, and further research is needed to establish clear recommendations for spirulina in cholera management.

More about spirulina
More about Cholera